SEARCH

SEARCH BY CITATION

References

  • 1
    Kaiser CI, Fidel JL, Roos M, et al. Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphoma. J Am Anim Hosp Assoc 2007;43:8592.
  • 2
    Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern med 2000;14:120124.
  • 3
    Boyce KL, Kitchell BE. Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 1999;35:201208.
  • 4
    Morrison-Collister KE, Rassnick KM, Northrup NC, et al. A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma. Vet Comp Oncol 2003;1:180190.
  • 5
    Greenberg CB, Boria PA, Borgatti-Jeffreys A, et al. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs. J Am Anim Hosp Assoc 2007;43:2732.
  • 6
    Gustafson NR, Lana SE, Mayer MN, et al. A preliminary assessment of whole-body radiotherapy interposed within a chemotherapy protocol for canine lymphoma. Vet Comp Oncol 2004;2:124131.
  • 7
    Williams LE, Johnson JL, Hauck ML, et al. Chemotherapy followed by half-body radiation therapy for canine lymphoma. J Vet Internl Medicine 2004;18:703709.
  • 8
    Rassnick KM, McEntee MC, Erb HN, et al. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med 2007;21:13641373.
  • 9
    Perez CA, Brady LW, Roti JL. Overview. In: Perez CA, Brady LW, ed. Principles and Practice of Radiation Oncology, 3rd ed. Philadelphia, PA: Lippincott-Raven; 1997:178.
  • 10
    Schlembach PJ, Wilder RB, Tucker SL, et al. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Int J Radiat Oncol Biol Phys 2000;48:11071110.
  • 11
    Wilder RB, Tucker SL, Ha CS, et al. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Int J Radiat Oncol Biol Phys 2001;49:1722.
  • 12
    Laing EJ, Fitzpatrick PJ, Binnington AG, et al. Half-body radiotherapy in the treatment of canine lymphoma. J Vet Intern Med 1989;3:102108.
  • 13
    Lurie DM, Kent MS, Fry MM, et al. A toxicity study of low-dose rate half-body irradiation and chemotherapy in dogs with lymphoma. Vet Comp Oncol 2008;6:257267.
  • 14
    Owen LN. TNM Classification of Tumors in Domestic Animals. Geneva, Switzerland: World Health Organization; 1980.
  • 15
    Modiano JF, Smith R, Wojcieszyn J, et al. The use of cytochemistry, immunophenotyping, flow cytometry, and in vitro differentiation to determine the ontogeny of a canine monoblastic leukemia. Vet Clin Pathol 1998;27:4049.
  • 16
    Laing EJ, Fitzpatrick PJ, Binnington AG, et al. Half-body radiotherapy. J Vet Intern Med 1989;3:96101.
  • 17
    Vail DM. Veterinary co-operative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncol 2004;2:194213.
  • 18
    Hall EJ. Radiobiology for the Radiobiologist, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000.
  • 19
    Salazar OM, Scarantino CW. Theoretical and practical uses of elective systemic (half-body) irradiation after 20 years of experimental designs. Int J Radiat Oncol Biol Phys 1997;39:907913.
  • 20
    Siedlecki CT, Kass PH, Jakubiak MJ, et al. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Can Vet J 2006;47:5259.
  • 21
    Moore AS, Cotter SM, Rand WM, et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15:348354.
  • 22
    Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704709.
  • 23
    Simon D, Nolte I, Eberle N, et al. Treatment of dogs with lymphoma using a 12-week maintenance-free combination chemotherapy protocol. J Vet Intern Med 2006;20:948954.
  • 24
    Zemann BI, Moore AS, Rand WM, et al. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med 1998;12:465470.
  • 25
    Stone MS, Goldstein MA, Cotter SM. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 1991;27:315321.
  • 26
    Myers NC, Moore AS, Rand WM, et al. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997;11:333339.
  • 27
    Withrow SJ, Vail DM. Withrow and McEwan's Small Animal Clinical Oncology, 4th ed. St Louis, MO: Saunders; 2007.
  • 28
    Vaughan A, Johnson JL, Williams LE. Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol. J Vet Intern Med 2007;21:13321339.
  • 29
    Axiak SM, Carreras JK, Hahn KA, et al. Hematologic changes associated with half-body irradiation in dogs with lymphoma. J Vet Intern Med 2006:13981401.